• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk Factors for Sensorineural Hearing Loss in Children and Adolescents with Sickle Cell Disease.镰状细胞病儿童和青少年感音神经性听力损失的危险因素
Iran J Otorhinolaryngol. 2025;37(3):123-133. doi: 10.22038/ijorl.2025.74314.3500.
2
Sensorineural hearing loss in adults with sickle cell anaemia.镰状细胞贫血成年患者的感音神经性听力损失
Afr J Med Med Sci. 2002 Mar;31(1):21-4.
3
Scoping Review of Predisposing Factors Associated with Sensorineural Hearing Loss in Sickle Cell Disease.镰状细胞病中与感音神经性听力损失相关的诱发因素的范围综述
West Afr J Med. 2023 Feb 28;40(2):209-216.
4
Prevalence of Sensorineural Hearing Loss in Pediatric Patients with Sickle Cell Disease: A Meta-analysis.镰状细胞病儿科患者感音神经性听力损失的患病率:一项荟萃分析。
Laryngoscope. 2021 May;131(5):1147-1156. doi: 10.1002/lary.29199. Epub 2020 Oct 22.
5
Comparing Hearing Loss in Children with Adults Living with Sickle Cell Disease and Sickle Cell Traits.比较儿童与成人镰状细胞病和镰状细胞特征患者的听力损失。
Niger J Clin Pract. 2024 Jan 1;27(1):74-81. doi: 10.4103/njcp.njcp_763_23. Epub 2024 Feb 5.
6
Sensorineural hearing loss in children with sickle cell disease.镰状细胞病患儿的感音神经性听力损失
Int J Pediatr Otorhinolaryngol. 2019 Mar;118:110-114. doi: 10.1016/j.ijporl.2018.12.002. Epub 2018 Dec 5.
7
Sensorineural hearing loss in sickle cell disease--a prospective study from Oman.镰状细胞病中的感觉神经性听力损失——来自阿曼的前瞻性研究。
Laryngoscope. 2011 Feb;121(2):392-6. doi: 10.1002/lary.21374.
8
Otological findings among Nigerian children with sickle cell anaemia.患有镰状细胞贫血症的尼日利亚儿童的耳科检查结果。
Int J Pediatr Otorhinolaryngol. 2008 May;72(5):659-63. doi: 10.1016/j.ijporl.2008.01.024. Epub 2008 Mar 11.
9
Association between hearing impairment, school performance and cognitive function in children and adolescents with sickle cell disease.镰状细胞病儿童和青少年的听力障碍、学业成绩与认知功能之间的关联
Trop Med Int Health. 2022 Mar;27(3):244-250. doi: 10.1111/tmi.13722. Epub 2022 Feb 1.
10
Cochlear implantation in children with sickle cell disease.镰状细胞病患儿的人工耳蜗植入
Pediatr Int. 2015;57(1):174-6. doi: 10.1111/ped.12413.

本文引用的文献

1
Perspectives of individuals with sickle cell disease on barriers to care.镰状细胞病患者对护理障碍的看法。
PLoS One. 2022 Mar 23;17(3):e0265342. doi: 10.1371/journal.pone.0265342. eCollection 2022.
2
Inner Ear Complications in Children and Adolescents with Sickle Cell Disease.儿童和青少年镰状细胞病的内耳并发症。
Hemoglobin. 2020 Nov;44(6):411-417. doi: 10.1080/03630269.2020.1837863. Epub 2020 Nov 8.
3
The emergence and prevalence of hearing loss in children with homozygous sickle cell disease.纯合子镰状细胞病患儿听力损失的出现与患病率
Int J Pediatr Otorhinolaryngol. 2019 Aug;123:69-74. doi: 10.1016/j.ijporl.2019.04.032. Epub 2019 Apr 24.
4
Sensorineural hearing loss in children with sickle cell disease.镰状细胞病患儿的感音神经性听力损失
Int J Pediatr Otorhinolaryngol. 2019 Mar;118:110-114. doi: 10.1016/j.ijporl.2018.12.002. Epub 2018 Dec 5.
5
Hidden hearing loss in children and adolescents with sickle cell anemia.镰状细胞贫血患儿及青少年的隐匿性听力损失
Int J Pediatr Otorhinolaryngol. 2019 Jan;116:186-191. doi: 10.1016/j.ijporl.2018.10.042. Epub 2018 Nov 2.
6
Childhood Hearing Loss in Patients With Sickle Cell Disease in the United States.美国镰状细胞病患者的儿童听力损失
J Pediatr Hematol Oncol. 2019 Mar;41(2):124-128. doi: 10.1097/MPH.0000000000001373.
7
Hearing loss in children with sickle cell disease: A prospective French cohort study.镰状细胞病患儿的听力损失:一项前瞻性法国队列研究。
Pediatr Blood Cancer. 2019 Jan;66(1):e27468. doi: 10.1002/pbc.27468. Epub 2018 Sep 24.
8
Prevalence and nature of hearing loss in a cohort of children with sickle cell disease.镰状细胞病患儿队列中的听力损失的流行情况和性质。
Pediatr Blood Cancer. 2019 Jan;66(1):e27457. doi: 10.1002/pbc.27457. Epub 2018 Sep 11.
9
Investigation of neutrophil-to-lymphocyte ratio and mean platelet volume in sudden hearing loss.突发性听力损失中中性粒细胞与淋巴细胞比值及平均血小板体积的研究
Braz J Otorhinolaryngol. 2015 Nov-Dec;81(6):636-41. doi: 10.1016/j.bjorl.2015.08.009. Epub 2015 Sep 7.
10
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio: novel markers for diagnosis and prognosis in patients with idiopathic sudden sensorineural hearing loss.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值:特发性突发性聋患者诊断和预后的新标志物。
Dis Markers. 2014;2014:702807. doi: 10.1155/2014/702807. Epub 2014 May 7.

镰状细胞病儿童和青少年感音神经性听力损失的危险因素

Risk Factors for Sensorineural Hearing Loss in Children and Adolescents with Sickle Cell Disease.

作者信息

Solomon Amos, Shofoluwe Nurudeen Adebola, Ahmad Hafsat, Isa Abdulkadir, Yunusa Shuiabu Iliyasu, Manir Hamza Anka

机构信息

Department of Pediatrics, Faculty of Clinical Scinces, College of Medical Sciences, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.

Division of Otorhinolaryngology, Department of Surgery, Faculty of Clinical Scinces, College of Medical Sciences, Ahmadu Bello University and Ahmadu Bello University Teaching Hospital, Zaria, Kaduna State, Nigeria.

出版信息

Iran J Otorhinolaryngol. 2025;37(3):123-133. doi: 10.22038/ijorl.2025.74314.3500.

DOI:10.22038/ijorl.2025.74314.3500
PMID:40453155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12126206/
Abstract

INTRODUCTION

Sickle cell disease (SCD) is a major global health burden with significant clinical, social, and economic impacts. Sensorineural hearing loss (SNHL) is an underreported complication of SCD that is, primarily attributed to vaso-occlusive crises and ischemia. This condition adversely affects the quality of life, education, and social integration, particularly among children in resource-limited settings. Understanding the risk factors for SNHL is crucial for prevention, early detection, and timely intervention. This study evaluated the prevalence of SNHL in children with SCD and identified associated risk factors.

MATERIALS AND METHODS

This prospective comparative study was conducted at a tertiary healthcare facility in Northwest Nigeria. A total of 250 children aged 5-16 years were enrolled, comprising 125 patients with confirmed sickle cell disease (SCD) in a steady state and 125 age- and sex-matched controls with a normal haemoglobin genotype (HbAA).

RESULTS

Bilateral SNHL was identified in 25.6% of SCD cases, whereas no SNHL was observed in the control group. The male-to-female ratio among the affected children was 1.2:1. Multivariate logistic regression revealed significant associations between SNHL and elevated white blood cell count (Odds Ratio {OR} 1.035; 95% Confidence Interval {CI} 1.020-1.050), elevated platelet count (OR 1.209; 95% CI 1.070-1.365), poor clinic attendance (OR 28.668; 95% CI 4.879-168.458; = < 0.001), non-compliance with SCD medications (OR 9.634; 95% CI 1.830-50.718; = 0.008), and frequent severe sickle cell crises requiring hospitalization (OR 2.106,; 95% CI 0.019-0.598; = 0.001).

CONCLUSION

This study highlights the high prevalence of SNHL in children with SCD and its association with modifiable risk factors. Routine audiological screening, consistent clinic attendance, medication adherence, and regular monitoring of haematological parameters are essential for early identification and management of SNHL. Targeted interventions can significantly improve the outcomes and reduce the burden of this debilitating complication.

摘要

引言

镰状细胞病(SCD)是一项重大的全球健康负担,具有重大的临床、社会和经济影响。感音神经性听力损失(SNHL)是SCD一种未被充分报告的并发症,主要归因于血管闭塞性危机和局部缺血。这种情况对生活质量、教育和社会融合产生不利影响,在资源有限环境中的儿童中尤为如此。了解SNHL的危险因素对于预防、早期发现和及时干预至关重要。本研究评估了SCD患儿中SNHL的患病率,并确定了相关危险因素。

材料与方法

这项前瞻性比较研究在尼日利亚西北部的一家三级医疗机构进行。共纳入250名5至16岁的儿童,包括125名病情稳定的确诊镰状细胞病(SCD)患者和125名年龄及性别匹配、血红蛋白基因型正常(HbAA)的对照者。

结果

在25.6%的SCD病例中发现双侧SNHL,而对照组未观察到SNHL。受影响儿童的男女比例为1.2:1。多因素逻辑回归显示,SNHL与白细胞计数升高(比值比{OR}1.035;95%置信区间{CI}1.020 - 1.050)、血小板计数升高(OR 1.209;95% CI 1.070 - 1.365)、门诊就诊情况差(OR 28.668;95% CI 4.879 - 168.458;P < 0.001)、不遵守SCD药物治疗(OR 9.634;95% CI 1.830 - 50.718;P = 0.008)以及频繁发生需要住院治疗的严重镰状细胞危机(OR 2.106;95% CI 0.019 - 0.598;P = 0.001)之间存在显著关联。

结论

本研究突出了SCD患儿中SNHL的高患病率及其与可改变危险因素的关联。常规听力筛查、持续门诊就诊、药物依从性以及血液学参数的定期监测对于SNHL的早期识别和管理至关重要。有针对性的干预措施可以显著改善结局并减轻这种使人衰弱的并发症的负担。